Klimek, L., Schendzielorz, P., & Pfaar, O. (2012). Specific subcutaneous immunotherapy with recombinant grass pollen allergens: First randomized dose-ranging safety study. Clinical & experimental allergy, 42(6), . https://doi.org/10.1111/j.1365-2222.2012.03971.x
Chicago-Zitierstil (17. Ausg.)Klimek, Ludger, Philipp Schendzielorz, und Oliver Pfaar. "Specific Subcutaneous Immunotherapy with Recombinant Grass Pollen Allergens: First Randomized Dose-ranging Safety Study." Clinical & Experimental Allergy 42, no. 6 (2012). https://doi.org/10.1111/j.1365-2222.2012.03971.x.
MLA-Zitierstil (9. Ausg.)Klimek, Ludger, et al. "Specific Subcutaneous Immunotherapy with Recombinant Grass Pollen Allergens: First Randomized Dose-ranging Safety Study." Clinical & Experimental Allergy, vol. 42, no. 6, 2012, https://doi.org/10.1111/j.1365-2222.2012.03971.x.